Small cholangiolocellular carcinoma that was difficult to distinguish from cholangiocellular carcinoma: a case report
暂无分享,去创建一个
K. Shirabe | H. Kuwano | S. Aishima | Tadashi Handa | K. Araki | N. Kubo | A. Watanabe | Norihiro Ishii | Takahiro Yamanaka | Mariko Tsukagoshi | T. Igarashi | M. Tsukagoshi
[1] Ke Hao,et al. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity. , 2017, Journal of hepatology.
[2] T. Hibi,et al. Liver transplantation for hepatobiliary malignancies: a new era of “Transplant Oncology” has begun , 2017, Surgery Today.
[3] O. Matsui,et al. Dynamic CT findings of cholangiolocellular carcinoma: correlation with angiography-assisted CT and histopathology , 2017, Abdominal Radiology.
[4] T. Yamashita,et al. Cholangiolocellular Carcinoma of the Liver Exhibiting High F-18 FDG Uptake. , 2016, The Tokai journal of experimental and clinical medicine.
[5] H. Kuwano,et al. Giant Cholangiolocellular Carcinoma With Early Recurrence That Was Difficult to Distinguish From Cholangiocellular Carcinoma: Report of a Case. , 2015, International surgery.
[6] Masakazu Yamamoto,et al. Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis , 2015, Surgery Today.
[7] Masakazu Yamamoto,et al. Long-term Survival of Patients with Cholangiolocellular Carcinoma After Curative Hepatectomy , 2014, Annals of Surgical Oncology.
[8] S. Forbes,et al. Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion. , 2014, Gastroenterology.
[9] T. Murakami,et al. Clinical application of 18F-fluorodeoxyglucose positron emission tomography for assessment and evaluation after therapy for malignant hepatic tumor , 2013, Journal of Gastroenterology.
[10] F. Giuliante,et al. Prognostic Significance of Tumor Doubling Time in Mass-Forming Type Cholangiocarcinoma , 2013, Journal of Gastrointestinal Surgery.
[11] T. Utsunomiya,et al. High expression of cancer stem cell markers in cholangiolocellular carcinoma , 2012, Surgery Today.
[12] T. Roskams,et al. Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes , 2012, Hepatology.
[13] A. K. Poyraz,et al. The role of ADC measurement in differential diagnosis of focal hepatic lesions. , 2012, European journal of radiology.
[14] T. Takada,et al. Morphometric and immunohistochemical study of cholangiolocellular carcinoma: comparison with non-neoplastic cholangiole, interlobular duct and septal duct , 2011, Journal of hepato-biliary-pancreatic sciences.
[15] A. Gouw,et al. Ductular reactions in human liver: Diversity at the interface , 2011, Hepatology.
[16] H. Honda,et al. Imaging of cholangiolocellular carcinoma of the liver. , 2010, European journal of radiology.
[17] U. Motosugi,et al. Cholangiolocellular Carcinoma of the Liver: Imaging Findings , 2009, Journal of computer assisted tomography.
[18] O. Kilickesmez,et al. Value of apparent diffusion coefficient measurement for discrimination of focal benign and malignant hepatic masses , 2009, Journal of medical imaging and radiation oncology.
[19] M. Matsuda,et al. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin , 2007, Hepatology.
[20] O. Sagol,et al. Contribution of diffusion-weighted MRI to the differential diagnosis of hepatic masses. , 2007, Diagnostic and interventional radiology.
[21] M. Kojiro,et al. Clinicopathologic study on cholangiolocellular carcinoma. , 2001, Oncology reports.
[22] T. Aiko,et al. Cholangiolocellular carcinoma of the liver: CT and MR findings. , 2000, Journal of computer assisted tomography.
[23] F. Kondo,et al. Pathogenesis of Cholangiolocellular Carcinoma: Possibility of an Interlobular Duct Origin. , 2015, Internal medicine.